Rosane Jorge-Vianna

Rio De Janeiro, RJ, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

High mobility group box 1, ATP, lipid mediators, and tissue factor are elevated in COVID-19 patients: HMGB1 as a biomarker of worst prognosis.

High mobility group box 1, ATP, lipid mediators, and tissue factor are elevated in COVID-19 patients: HMGB1 as a biomarker of worst prognosis.

Journal: Clinical and translational science

Published: May 26, 2022

The -1195A>G polymorphism in Ciclooxygenase-2 gene is associated with lower risk of endometriosis.

The -1195A>G polymorphism in Ciclooxygenase-2 gene is associated with lower risk of endometriosis.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: May 25, 2020

ABCB1 and ERCC1 gene polymorphisms are associated with nephro- and hepatotoxicity to carboplatin/paclitaxel-based chemotherapy in patients with gynecologic cancers.

ABCB1 and ERCC1 gene polymorphisms are associated with nephro- and hepatotoxicity to carboplatin/paclitaxel-based chemotherapy in patients with gynecologic cancers.

Journal: European journal of clinical pharmacology

Published: January 08, 2020

A novel and simple LC-MS/MS quantitative method for dextromethorphan and dextrorphan in oral fluid.

A novel and simple LC-MS/MS quantitative method for dextromethorphan and dextrorphan in oral fluid.

Journal: Bioanalysis

Published: June 21, 2019

Impact of gene polymorphisms on the systemic toxicity to paclitaxel/carboplatin chemotherapy for treatment of gynecologic cancers.

Impact of gene polymorphisms on the systemic toxicity to paclitaxel/carboplatin chemotherapy for treatment of gynecologic cancers.

Journal: Archives of gynecology and obstetrics

Published: October 23, 2018

PTGS2 polymorphism rs689466 favors breast cancer recurrence in obese patients.

PTGS2 polymorphism rs689466 favors breast cancer recurrence in obese patients.

Journal: Endocrine-related cancer

Published: December 07, 2017

Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis.

Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis.

Journal: Breast cancer (Dove Medical Press)

Published: July 04, 2017

Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.

Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.

Journal: PloS one

Published: June 28, 2017

DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis.

DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis.

Journal: Cancer biology & therapy

Published: May 06, 2017

Modulation of the prostaglandin-endoperoxide synthase 2 gene expression by variant haplotypes: influence of the 3'-untranslated region.

Modulation of the prostaglandin-endoperoxide synthase 2 gene expression by variant haplotypes: influence of the 3'-untranslated region.

Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica

Published: April 25, 2017

Combined effect of vascular endothelial growth factor and its receptor polymorphisms in endometriosis: a case-control study.

Combined effect of vascular endothelial growth factor and its receptor polymorphisms in endometriosis: a case-control study.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: July 18, 2016

Prognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancer.

Prognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancer.

Journal: Cancer biology & therapy

Published: May 20, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026